CHD Chemicals Limited is a Chemicals & Petrochemicals company. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
| ₹ crore · consolidated | FY21 | FY22 | FY23 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 69 | 32 | 19 | 7 | 5 |
| EBITDA (ex other income) | 1 | 1 | 1 | 0 | (0) |
| margin % | 1.0 | 2.6 | 3.3 | 0.3 | (6.3) |
| Owners' profit | 0 | 0 | 0 | (0) | (0) |
| EPS, as reported (₹) | 0.05 | 0.16 | 0.06 | 0.19 | 0.31 |
| ROE % · ROCE % | 0.4 · 3.1 | 0.0 · 0.0 | 0.5 · 2.4 | (1.5) · 0.3 | (2.5) · (0.4) |
| Debt / equity (x) | 0.48 | 0.28 | 0.21 | 0.51 | 0.45 |
| Cash from operations | (4) | (13) | 11 | 0 | 1 |
| Capex | (0) | (0) | (0) | (0) | (0) |
| ₹ crore | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 2 |
| Profit before tax | (0) | 0 | (0) | 0 | (0) | (0) | (0) | (0) |
| Net profit | (0) | 0 | (0) | 0 | (0) | (0) | (0) | (0) |
| EPS (₹) | 0.00 | 1.73 | (1.99) | 0.06 | 0.15 | 0.05 | 0.04 | 0.02 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| UNIPHOS ENTERPRISES LTD | 635 | 31.4 | 0.26 | — | 0.8 | 0.8 | — | — |
| VINYL CHEMICALS (I) LTD. | 402 | 17.3 | 3.09 | — | 12.7 | 16.8 | — | 9.0 |
| EVEXIA LIFECARE LIMITED | 310 | 55.0 | 0.71 | 108.2 | 0.4 | 0.3 | 0.7 | 3.3 |
| BHAVIK ENTERPRISES LIMITED | 293 | 19.8 | — | — | — | 11.1 | — | — |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 8 Sept 2026 · Annual Report FY26: Revenue Down, Losses Widen; Capital Hike and Diversification Planned | results | high | — | — |
| 8 Sept 2026 · CHD Chemicals announces book closure from Sept 24 to Sept 30 for AGM | compliance | minimal | — | — |
| 8 Sept 2026 · AGM on Sept 30 with share capital hike and diversification on agenda | board shareholder meetings | low | — | — |
| 8 Sept 2026 · Board OKs FY26 results, capital hike to Rs 36 Cr, AGM on Sept 30 | results | high | — | — |
| 5 Sept 2026 · Board meeting on Sept 8 to consider annual reports and capital hike | board shareholder meetings | low | — | — |
| 14 Aug 2026 · CHD Chemicals posts Q1 loss of Rs 12.27L, revenue up 28% YoY | results | high | — | — |
| 11 Aug 2026 · Board meeting on 14 Aug 2026 to consider Q1 FY27 audited results | results | low | — | — |
| 30 Jun 2026 · CHD Chemicals closes trading window ahead of Q1 results | compliance | minimal | — | — |
| 23 Jun 2026 · Non-Executive Director Mrs Santosh Rani resigns from CHD Chemicals board | management changes | low | — | — |
| 30 May 2026 · declaration of quarter and year end result 31st march 2026 | results | high | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| A-1 LIMITED |
| 289 |
| 26.2 |
| 5.34 |
| 26.2 |
| 11.1 |
| 14.8 |
| — |
| 3.5 |
| SHANKAR LAL RAMPAL LTD | 245 | 13.3 | 2.00 | — | 11.0 | 14.7 | — | 9.4 |
| MYSORE PETRO CHEMICALS L | 93 | 17.1 | 0.41 | 100.3 | 0.4 | 0.2 | 18.0 | (0.4) |
| Yash Chemex Limited | 53 | 24.1 | 0.87 | 14.4 | 4.0 | 5.2 | 20.6 | (0.0) |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 23.0 | 17.2 | 10 of 14 | 31% |
| P/B | 0.5 | 0.8 | 4 of 10 | 67% |
| ROCE | (1.4) | 3.0 | 12 of 14 | 15% |
| ROE | (2.5) | 0.8 | 9 of 10 | 11% |
| Debt / Equity | 0.5 | 0.0 | 9 of 10 | 11% |
| EBITDA margin | 3.2 | 3.3 | 6 of 9 | 38% |
| Revenue growth | 6.7 | 10.9 | 7 of 11 | 40% |
| Profit growth | (125.3) | 5.7 | 8 of 10 | 22% |
| Market cap | 6 | 93 | 12 of 13 | 8% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
